Article No
155-98-667
Specifications
| NCBI Number | 12478 |
| Accession Number | P25918 |
| Application | FC, FLISA, ICC, WB |
| Article No | 155-98-667 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT, FO, GL |
| Clone | MB19-1 |
| Clone Type | monoclonal |
| Concentration | 0.5 mg/ml |
| Conjugation | Unconjugated |
| Description | CD19 Antibody [MB19-1] |
| Supplier | ProSci |
| Entrez Gene ID | 12478 |
| Format | Liquid |
| Gene Symbol | Cd19 |
| Immunogen | CD19+ mouse pre-B cell line 300.19 |
| Isotype | IgA |
| Notes | CD19 is a monomeric transmembrane glycoprotein expressed at relatively constant levels throughout B cell development from early pro-B/pre-B cells (i.e. B220+/CD43+/HSA+) through fully differentiated B cell stages. Terminally differentiated plasma cells do not express CD19. In humans, the CD19 molecule on the surface of mature B cells associates with CD21 (CR-2) and CD81 (TAPA-1), and this multimolecular complex synergizes with surface immunoglobulin to provide signal transduction and promote cellular activation. All splenic and peritoneal IgM+ cells of both B-1 and B-2 lineages are CD19+, with B-1 cells expressing higher levels of CD19 than B-2 cells in these sites. Studies with CD19-deficient mice have suggested that this molecule may not be required for normal generation and maturation of B cells in the bone marrow. |
| Alias Names | B4, Leu-12 |
| Previous Article No | 155-98-667-0.5 |
| Product Type | Antibodies Primary |
| Protocol | CD19 Antibody [MB19-1] for use in flow cytometry, immunoprecipitation, and activation assays. |
| Research area | Immunology |
| Shipping Information | BLUE ICE |
| Size | 0.5 mg |
| Source / Host | mouse |
| Species Reactivity | mouse |
| Storage | 4°C |
| Substrate / Buffer | Supplied in borate buffered saline, pH 8.2; No preservatives or amine-containing buffer salts added |
| Technical Specifications | CD19 Antibody [MB19-1] for use in flow cytometry, immunoprecipitation, and activation assays. |
| UniProt Number | P25918 |
| Product Page Updated | 2024-01-03T13:34:25.701Z |
